Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Plan for Crossflo?

Plan for Crossflo?

posted on Jan 11, 2009 10:59AM

From the last Shareholder letter:

"We expect to provide a plan for Crossflo’s revenues for the period March 1, 2009 through February 28, 2010 (aligned with Patriot fiscal quarters) in January."

I thought, we'd get the plan BEFORE the shareholder conference call to ask some questions regarding the Crossflo plan.

So far I'm scratching my head, what my main questions would be, because the only question I have cannot be answered by RG, but only by the guy from the USPTO...

Good night from Germany and let's hope for a little positive surprise next week.



Share
New Message
Please login to post a reply